An exhilarating development in cancer research in the last 10 years now consists of trials occurring at four cancer cure centers in America. The centers are utilizing an extremely responsive and new blood test developed at the Massachusetts General Hospital (MGH) in Boston. The test may transform the means for cancer healing. As tumors develop, they discharge cancerous cells into the blood stream. This fresh test pledges to identify the tiniest vestiges of cancer cells disseminating in the blood.
Dr. Dennis Haber, who is one of the researchers, has stated that, for every malignant cell in the blood, there are in excess of a billion blood cells in movement. In the latest test, a blood sample is moved across a microchip that is dealt with exceptional glue. Subsequently, Dr. Mehmet Toner explains that all these cells run through the chip, but only cancerous cells are detected by the chip and they bond with it, with the nontoxic cells being forwarded. The expectation is that, by appraising the amount and sorts of cancerous cells in the blood, physicians can ascertain whether a patient’s treatment is effective or not.
Dr. Elmer Huerta is a former President associated with the American Cancer Society (ACA). He has remarked that, in the treatment given by him, he observes if the tumor is lessening and vanishing in an X-ray and CT scan as well as an MRI. However, on occasions, only months later, a biopsy or X-ray illustrates if the treatment is effectual or not. During that period, crucial time is lost if the cancer lengthens. With this fresh test, physicians will be able to discern instantaneously if the patient still experiences cancer. This test, as per Dr. Pearson, will ensure that the follow-up of cancer sufferers will be more accurate and helpful. Pearson has stated that prudent usage of this technology will enable the detection of repetitive cancer cases earlier and fresh pills can then be supplied to neutralize that cancer.
All this research, however, is still in nascent stages and will take about five years to be comprehensive. Nevertheless, if it is successful, the researchers intend to popularize this test and make it broadly accessible.